Y-27632 Pack Size:5 mg 4-Hydroxytamoxifen ((Z)-4-Hydroxytamoxifen) induces CRISPR/Cas9 systems

4-Hydroxytamoxifen ((Z)-4-Hydroxytamoxifen) induces CRISPR/Cas9 systems based on ER mediated nucleus translocation

MRTX1133 prevents SOS1-catalyzed nucleotide exchange and/or formation of the KRAS G12D/GTP/RAF1 complex

Invent Biotechnologies)

SB-431542 has inhibitory activity for ALK4

Y-27632 Pack Size:5 mg 4-Hydroxytamoxifen ((Z)-4-Hydroxytamoxifen) induces CRISPR/Cas9 systemsY 27632 is an orally active, ATP competitive inhibitor of ROCK I and ROCK II, with Kis of 220 and 300 nM, respectively. Y 27632 attenuates Doxorubicin induced apoptosis of human cardiac stem cells. Y 27632 also suppresses dissociation induced apoptosis of murine prostate stem progenitor cells. Y 27632 primes human induced pluripotent stem cells (hIPSCs) to selectively differentiate towards mesendodermal lineage via epithelial mesenchymal transition